News | December 08, 2014

High-Quality Hospitals Deliver Lowest-Cost Care for Congenital Heart Surgery Patients

Study finds costs of care differed by five-fold across 27 hospitals

December 8, 2014 — Children’s hospitals in the United States delivering the highest-quality care for children undergoing heart surgery also appear to provide care most efficiently at a low cost, according to research led by the University of Michigan and presented at the American Heart Association Scientific Sessions in Chicago.

Congenital heart defects are the most common birth defects, and each year more than 30,000 congenital heart operations are performed across U.S. children’s hospitals. Congenital heart defects are also one of the most expensive pediatric conditions to treat.

Given the many current initiatives in healthcare aimed at both improving quality of care and reducing costs, or optimizing value, University of Michigan researchers along with collaborators decided to study whether it is possible to deliver high-quality heart care but also at a low cost. The study’s lead author was Sara K. Pasquali, M.D., associate professor of pediatric cardiology within the Michigan Congenital Heart Center at U-M’s C.S. Mott Children’s Hospital and U-M’s Center for Healthcare Outcomes and Policy.

The researchers studied 30,670 patients ages 0-18 years undergoing heart surgery across 27 different hospitals, using a unique dataset of merged clinical and cost information from the Society of Thoracic Surgeons and Children’s Hospital Association.

According to Pasquali, costs of care differed by five-fold across these hospitals. The lowest-cost hospitals had significantly lower mortality rates compared to the other hospitals. The low-cost hospitals also had shorter lengths of stay after surgery and fewer post-operative complications.

Interestingly, the low-cost hospitals tended to be larger volume centers, who were able to achieve these outcomes despite treating a more high-risk patient population.

“The care of children with congenital heart conditions is complex and requires significant investment of resources. It has been unclear whether there are centers able to provide high quality care, but also at a low cost,” said Pasquali, who is a member of the Institute for Healthcare Policy and Innovation at U-M.

“Understanding these relationships is critical in the appropriate design of policies aiming to optimize healthcare value in this population and others. For example, one would not want to provide incentives to low-cost hospitals if these low costs were due to poor clinical outcomes, such as high rates of mortality.”

What this new research shows, Pasquali said, is that lower-cost hospitals seem to be doing the right thing: They are delivering the highest-quality care to children undergoing heart surgery.

“In addition, these results suggest that initiatives that aiming to improve quality of care and outcomes, may also hold the potential to reduce costs in this population she says.

For more information: www.mottchildren.org/congenital

Related Content

Hershey's Chocolate display with samples and coco pods at the American College of Cardiology (ACC) 2012 annual meeting. The company was making the case that chocolate can be good for your heart, which is now supported by several studies. Photo by Dave Fornell

Hershey's Chocolate display with samples and coco pods at the American College of Cardiology (ACC) 2012 annual meeting. The company was making the case that chocolate can be good for your heart, which is now supported by several studies. Photo by Dave Fornell

News | Cardiovascular Clinical Studies | July 22, 2020
July 22, 2020 — Eating chocolate at least once a week is linked with a reduced risk of heart disease, according to re
The first 3-D images have been created of an RNA molecule known as "Braveheart" for its role in transforming stem cells into heart cells. Credit: Image courtesy Los Alamos National Laboratory

The first 3-D images have been created of an RNA molecule known as "Braveheart" for its role in transforming stem cells into heart cells. Credit: Image courtesy Los Alamos National Laboratory

News | Cardiovascular Clinical Studies | January 20, 2020
January 20, 2020 — Scientists at Los Alamos and international partners have created the first 3-D images of a special
Top Cardiology New in 2019 From the European Society of Cardioloigy (ESC)
News | Cardiovascular Clinical Studies | December 23, 2019
Environmental and lifestyle issues were popular this year, with pick up from both...
News | Cardiovascular Clinical Studies | November 26, 2019
November 26, 2019 — The University of Connecticut (UConn) Department of Kinesiology and Hartford Healthcare have sele
FDA Issues Final Guidance on Live Case Presentations During IDE Clinical Trials
News | Cardiovascular Clinical Studies | July 10, 2019
The U.S. Food and Drug Administration (FDA) issued the final guidance “Live Case Presentations During Investigational...
Veradigm Partners With American College of Cardiology on Next-generation Research Registries
News | Cardiovascular Clinical Studies | July 03, 2019
The American College of Cardiology (ACC) has partnered with Veradigm, an Allscripts business unit, to power the next...
New FDA Proposed Rule Alters Informed Consent for Clinical Studies
News | Cardiovascular Clinical Studies | November 19, 2018
The U.S. Food and Drug Administration (FDA) is proposing to add an exception to informed consent requirements for...
A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp